Early rheumatoid arthritis: strategies for prevention and management

Best Practice and Research in Clinical Rheumatology - Tập 21 Số 1 - Trang 27-42 - 2007
Bernard Combe1
1Immuno-Rhumatologie Hôpital Lapeyronie, CHU de Montpellier, University Montpellier I, 371, Avenue du Doyen Gaston Giraud 34295 Montpellier cedex 5, France. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Visser, 2005, Early diagnosis of rheumatoid arthritis, Best Practice and Research Clinical Rheumatology, 19, 55, 10.1016/j.berh.2004.08.005

Dixon, 2005, Does early rheumatoid arthritis exist?, Best Practice and Research Clinical Rheumatology, 19, 37, 10.1016/j.berh.2004.08.003

Huizinga, 2002, Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis, Arthritis and Rheumatism, 46, 1155, 10.1002/art.10195

Combe, 2006, EULAR recommendations for the management of early arthritis, Annals of the Rheumatic Diseases, 10.1136/ard.2005.044354

Morel, 2005, How to predict prognosis in early rheumatoid arthritis, Best Practice and Research Clinical Rheumatology, 19, 137, 10.1016/j.berh.2004.08.008

Combe, 2004, Should patients with recent-onset polyarthritis receive aggressive treatment?, Joint, Bone, Spine: Revue du Rhumatisme, 71, 475, 10.1016/j.jbspin.2004.07.005

Sharp, 2000, Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group, Arthritis and Rheumatism, 43, 495, 10.1002/1529-0131(200003)43:3<495::AID-ANR4>3.0.CO;2-U

Landewe, 2002, COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention, Arthritis and Rheumatism, 46, 347, 10.1002/art.10083

Korpela, 2004, Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying anti-rheumatic drugs: five-year experience from the FIN-RACo study, Arthritis and Rheumatism, 50, 2072, 10.1002/art.20351

Goekoop-Ruiterman, 2005, Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial, Arthritis and Rheumatism, 52, 3381, 10.1002/art.21405

Lipsky, 2000, Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group, The New England Journal of Medicine, 343, 1594, 10.1056/NEJM200011303432202

Klareskog, 2004, Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial, Lancet, 363, 675, 10.1016/S0140-6736(04)15640-7

Keystone, 2004, Arthritis and Rheumatism, 50, 1400, 10.1002/art.20217

Lard, 2001, Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies, The American Journal of Medicine, 111, 446, 10.1016/S0002-9343(01)00872-5

Bukhari, 2003, Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study, Arthritis and Rheumatism, 48, 46, 10.1002/art.10727

Nell, 2004, Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology (Oxford), 43, 906, 10.1093/rheumatology/keh199

Grigor, 2004, Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial, Lancet, 364, 263, 10.1016/S0140-6736(04)16676-2

Emery, 2002, Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide, Annals of the Rheumatic Diseases, 61, 290, 10.1136/ard.61.4.290

European Action Towards Better Musculoskeletal Health: A Public Health Strategy to Reduce the Burden of Musculoskeletal Conditions. A Bone and Joint Decade Report, 2004. The European Bone and Joint Health Strategies Project. The Bone and Joint Decade, Lund, Sweden. Available at: http://ec.europa.eu/health/ph_project/2000/promotion/fp_promotion_2000_frep_15_en.pdf.

Guillemin, 1994, Functional disability in early rheumatoid arthritis: description and risk factors, Journal of Rheumatology, 21, 1051

Wolfe, 1991, The assessment and prediction of functional disability in rheumatoid arthritis, The Journal of Rheumatology, 18, 1298

Jantti, 1999, Work disability in an inception cohort of patients with seropositive rheumatoid arthritis in the first years of the disease, Rheumatology, 38, 423, 10.1093/rheumatology/38.11.1138

Anderson, 2000, Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration, Arthritis and Rheumatism, 43, 22, 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9

Haagsma, 1997, Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial, British Journal of Rheumatology, 36, 1082, 10.1093/rheumatology/36.10.1082

Dougados, 1999, Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components, Annals of the Rheumatic Diseases, 58, 220, 10.1136/ard.58.4.220

Tugwell, 1995, Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group, The New England Journal of Medicine, 333, 137, 10.1056/NEJM199507203330301

Gerards, 2003, Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial, Annals of the Rheumatic Diseases, 62, 291, 10.1136/ard.62.4.291

Genovese, 2002, Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes, Arthritis and Rheumatism, 46, 1443, 10.1002/art.10308

St Clair, 2004, Active-controlled study of patients receiving infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial, Arthritis and Rheumatism, 50, 3432, 10.1002/art.20568

Breedveld, 2006, Arthritis and Rheumatism, 54, 26, 10.1002/art.21519

Welsing, 2004, The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis, Arthritis and Rheumatism, 50, 2082, 10.1002/art.20350

van der Heijde, 2005, Comparison of different definitions to classify remission and sustained remission: one year TEMPO results, Annals of the Rheumatic Diseases, 64, 1582, 10.1136/ard.2004.034371

Pinals, 1981, Preliminary criteria for clinical remission in rheumatoid arthritis, Arthritis and Rheumatism, 24, 1308, 10.1002/art.1780241012

Prevoo, 1996, Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score, British Journal of Rheumatology, 35, 1101, 10.1093/rheumatology/35.11.1101

Klarlund, 2000, Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group, Annals of the Rheumatic Diseases, 59, 521, 10.1136/ard.59.7.521

McQueen, 2003, Bone oedema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis, Arthritis and Rheumatism, 48, 1814, 10.1002/art.11162

Ejbjerg, 2004, Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis, Arthritis and Rheumatism, 50, 1097, 10.1002/art.20135

Klareskog, 2006, New model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination, Arthritis and Rheumatism, 54, 38, 10.1002/art.21575

Wienecke, 2004, Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis, Cochrane Database Systematic Reviews, 10.1002/14651858.CD003789.pub2

Gotzsche, 2004, Short-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis, Cochrane Database Systematic Reviews

Quinn, 2003, Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol, Arthritis and Rheumatism, 48, 3039, 10.1002/art.11269

van Everdingen, 2002, Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial, Annals of Internal Medicine, 136, 1, 10.7326/0003-4819-136-1-200201010-00006

Rau, 2000, Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis – preliminary results of a multicenter, randomized, parallel, double blind study, Zeitschrift für Rheumatologie, 59, II/90, 10.1007/s003930070026

Proudman, 2000, Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intra-articular corticosteroids compared with sulfasalazine alone, Arthritis and Rheumatism, 43, 1809, 10.1002/1529-0131(200008)43:8<1809::AID-ANR17>3.0.CO;2-D

Maetzel, 2000, Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs, Rheumatology (Oxford), 39, 975, 10.1093/rheumatology/39.9.975

Weinblatt, 1994, Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study, Arthritis and Rheumatism, 37, 1492, 10.1002/art.1780371013

Ottawa Panel, 2004, Ottawa Panel evidence-based clinical practice guidelines for therapeutic exercises in the management of rheumatoid arthritis in adults, Physical Therapy, 84, 934

Van Den Ende, 2000, Dynamic exercise therapy for rheumatoid arthritis, Cochrane Database Systematic Reviews

Steultjens, 2004, Occupational therapy for rheumatoid arthritis, Cochrane Database Systematic Reviews, 10.1002/14651858.CD003114.pub2

Hafstrom, 2001, A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens, Rheumatology (Oxford), 40, 1175, 10.1093/rheumatology/40.10.1175

Riemsma, 2003, Patient education for adults with rheumatoid arthritis, Cochrane Database Systematic Reviews, 10.1002/14651858.CD003688

Visser, 2002, How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis, Arthritis and Rheumatism, 46, 357, 10.1002/art.10117

Combe, 2001, Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study, Arthritis and Rheumatism, 44, 1736, 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I

Dixey, 2004, Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS), The Journal of Rheumatology Supplement, 69, 48

Meyer, 2003, Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage, Annals of the Rheumatic Diseases, 62, 120, 10.1136/ard.62.2.120

Yelin, 1998, Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition, Medical Care, 36, 513, 10.1097/00005650-199804000-00007

Criswell, 1997, Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists, Journal of Rheumatology, 24, 2283